Dabur India - Healthcare Continues To Post Strong Growth In Q3: Dolat Capital 
A range of Dabur India Ltd. products (Photographer: Prashanth Vishwanathan/Bloomberg)  

Dabur India - Healthcare Continues To Post Strong Growth In Q3: Dolat Capital 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Dabur India Ltd.’s Q3 FY21 results were in line with our estimate. Domestic fast moving consumer goods volumes increased by 18.1% YoY - second consecutive quarter of double digit volume growth.

Growth in the domestic market was driven by health care (up 28.1%) and home and personal care (up 15.9%) business.

Healthcare contribution grew from 40% in Q3 FY20 to 44% in Q3 FY21 led by market share gains in chyawanprash and honey.

The healthcare category is expected to grow faster post Covid-19 with new launches

Click on the attachment to read the full report:

Dolat Capital Dabur India Q3FY21 Result Update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.